Antibody-interleukin 2 fusion proteins: a new approach to cancer therapy

J Clin Lab Anal. 1996;10(3):160-6. doi: 10.1002/(SICI)1098-2825(1996)10:3<160::AID-JCLA9>3.0.CO;2-F.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / therapeutic use
  • Humans
  • Immunotherapy / methods*
  • Immunotherapy, Adoptive
  • Interleukin-2 / therapeutic use*
  • Melanoma / immunology
  • Melanoma / therapy
  • Mice
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Neuroblastoma / immunology
  • Neuroblastoma / secondary
  • Neuroblastoma / therapy
  • Recombinant Fusion Proteins / therapeutic use*
  • Tumor Cells, Cultured

Substances

  • Antibodies, Monoclonal
  • Interleukin-2
  • Recombinant Fusion Proteins